Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02721082 · ClinicalTrials.gov registry record · Phase 4
Changing the Default for Tobacco Treatment
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,000
- Enrollment target
NCT02721082: Completed Phase 4 study, sponsored by University of Kansas Medical Center.
NCT02721082 is a Phase 4 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 1,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02721082, a Phase 4 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.
Primary Outcome
7-day, self-reported and verified cigarette abstinence.
Interventions
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Opt Out Treatment Program
- BEHAVIORAL Opt In Treatment Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2020-12-09 |
| Phase | Phase 4 |
What the finished NCT02721082 record still lists
NCT02721082 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% higher).
The record links to 0 conditions, and to 3 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT02721082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02721082 about?
NCT02721082 is a clinical study titled "Changing the Default for Tobacco Treatment". The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.
What is the current status of trial NCT02721082?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,000 participants. The study started on 2016-09-01. Estimated completion is 2020-12-09.
What interventions are being tested in trial NCT02721082?
The interventions under investigation include: Nicotine Replacement Therapy (DRUG), Opt Out Treatment Program (BEHAVIORAL), Opt In Treatment Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02721082?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02721082's enrollment target sits among peer trials
1,000 66th of 2000 higher than 1,929 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI